All authorized agents for medicine are hereby informed that priority registration will be granted for the following products.

1) Clonidine oral tablets 100mg

2) Guanfacine oral tablets 2mg

3) Fluoxetine oral tablets 10mg

4) Methylphenidate tablets extended-release form

5) Olanzapine Oral Dispersible Tablets 10mg

6) Aripiprazole oral tablets 10mg

7) Sertraline oral tablets 25mg

(Date: 19 March 2022)